Search

Your search keyword '"Wagner-Drouet, Eva-Maria"' showing total 10 results

Search Constraints

Start Over You searched for: Author "Wagner-Drouet, Eva-Maria" Remove constraint Author: "Wagner-Drouet, Eva-Maria" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
10 results on '"Wagner-Drouet, Eva-Maria"'

Search Results

1. Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison

2. Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

3. Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation

4. Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

5. Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial

6. Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial

7. Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT

8. A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

9. Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial

Catalog

Books, media, physical & digital resources